| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZF_CXXC | 7.68e-05 | 11 | 148 | 3 | PS51058 | |
| Domain | Znf_CXXC | 7.68e-05 | 11 | 148 | 3 | IPR002857 | |
| Domain | zf-CXXC | 7.68e-05 | 11 | 148 | 3 | PF02008 | |
| Pubmed | PPFIBP1 CDK19 CHD8 ADGRV1 ZNRF3 SETBP1 PLEKHA5 KDM2A MINAR1 UNC80 | 8.59e-08 | 225 | 157 | 10 | 12168954 | |
| Pubmed | NCOA3 WDR36 CECR2 CHD8 CHD1 HUWE1 CNTROB PHF1 NUP133 KMT2A ING4 TRMT1L MUC4 | 2.41e-07 | 469 | 157 | 13 | 27634302 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 KIAA0930 HIVEP2 KHNYN C15orf39 CHD8 CORO1B HUWE1 CNTROB KANSL3 HIVEP3 MST1R SNX30 UBN1 ZNRF3 MLLT6 ZC3H7B MMP14 ADAT1 | 6.60e-07 | 1105 | 157 | 19 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 SPATA31E1 PICALM SYNGAP1 ARRB2 UBN1 XIRP2 SETBP1 MLLT6 PLEKHO1 GAB1 | 4.52e-06 | 430 | 157 | 11 | 35044719 |
| Pubmed | 4.70e-06 | 25 | 157 | 4 | 17684299 | ||
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 4.97e-06 | 8 | 157 | 3 | 32179550 | |
| Pubmed | 6.47e-06 | 27 | 157 | 4 | 23824573 | ||
| Pubmed | KIAA0930 SH3BP1 APOBEC3A ZNRF3 FBXO7 SAMM50 ZC3H7B MPPED1 MAPK8IP2 | 9.73e-06 | 300 | 157 | 9 | 10591208 | |
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 1.06e-05 | 10 | 157 | 3 | 29276034 | |
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 2.02e-05 | 2 | 157 | 2 | 23100278 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12124344 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12461747 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25205731 | ||
| Pubmed | Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia. | 2.02e-05 | 2 | 157 | 2 | 31395741 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20404140 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 7984047 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22363754 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 9618760 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 2.02e-05 | 2 | 157 | 2 | 33526815 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 39181201 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28931893 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23544943 | ||
| Pubmed | Shroom4 (Kiaa1202) is an actin-associated protein implicated in cytoskeletal organization. | 2.02e-05 | 2 | 157 | 2 | 17009331 | |
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 2.02e-05 | 2 | 157 | 2 | 36449053 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22717029 | ||
| Pubmed | MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC. | 2.02e-05 | 2 | 157 | 2 | 26393880 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19144982 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 24323992 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19617579 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22836751 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36928256 | ||
| Pubmed | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties. | 2.02e-05 | 2 | 157 | 2 | 2247438 | |
| Pubmed | The Concerted Action of E2-2 and HEB Is Critical for Early Lymphoid Specification. | 2.02e-05 | 2 | 157 | 2 | 30936870 | |
| Pubmed | TF and TCF4 gene polymorphisms are linked to autism spectrum disorder: a case-control study. | 2.02e-05 | 2 | 157 | 2 | 36448207 | |
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 2.02e-05 | 2 | 157 | 2 | 24096970 | |
| Pubmed | NCOA3 NOL4 C15orf39 CHD8 HUWE1 RBBP8NL ARRB2 ANAPC1 TET1 PLEKHA5 | 2.20e-05 | 418 | 157 | 10 | 34709266 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | WDR36 POLR2G GPATCH2 CHD8 HUWE1 TBL3 MAP3K4 ANAPC1 NUP133 TRMT1L | 3.40e-05 | 440 | 157 | 10 | 34244565 |
| Pubmed | 3.95e-05 | 15 | 157 | 3 | 26395479 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP2 CDK19 GPATCH2 IQCN ADGRV1 HUWE1 RBBP8NL OGDH MAP3K12 KANSL3 HIVEP3 SNX30 ARRB2 SETBP1 NTN1 KDM2A SAMM50 ICA1L MAML3 | 4.53e-05 | 1489 | 157 | 19 | 28611215 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | FNIP2 ABHD17A AMFR TCF4 GRB7 OGDH C3orf20 USP21 PNPT1 ERLIN2 TET1 EHD1 STAU2 FBXO7 KLF17 ILDR1 TCF7L1 | 4.98e-05 | 1242 | 157 | 17 | 30973865 |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 23053434 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 30236127 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 33778834 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 26770020 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 31563850 | ||
| Pubmed | ALF1, a basic helix-loop-helix transcription factor, maps to mouse chromosome 9. | 6.06e-05 | 3 | 157 | 2 | 8833258 | |
| Pubmed | E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. | 6.06e-05 | 3 | 157 | 2 | 17082585 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 10930438 | ||
| Pubmed | Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia. | 6.06e-05 | 3 | 157 | 2 | 16815892 | |
| Pubmed | Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. | 6.06e-05 | 3 | 157 | 2 | 18371366 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 10207097 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 12646957 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 18384878 | ||
| Pubmed | Dynamic Expression of Membrane Type 1-Matrix Metalloproteinase (Mt1-mmp/Mmp14) in the Mouse Embryo. | 6.06e-05 | 3 | 157 | 2 | 34572097 | |
| Pubmed | Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy. | 6.06e-05 | 3 | 157 | 2 | 16779968 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 27483328 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24204560 | ||
| Pubmed | Genome-wide association study of major recurrent depression in the U.K. population. | 6.06e-05 | 3 | 157 | 2 | 20516156 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24939955 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22948384 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24043765 | ||
| Pubmed | The helix-loop-helix gene E2A is required for B cell formation. | 6.06e-05 | 3 | 157 | 2 | 8001124 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 30593567 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24199708 | ||
| Pubmed | Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. | 6.06e-05 | 3 | 157 | 2 | 26752546 | |
| Pubmed | Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. | 6.06e-05 | 3 | 157 | 2 | 34625792 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22046413 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 6.06e-05 | 3 | 157 | 2 | 17592322 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 18854153 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22406270 | ||
| Pubmed | Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia. | 6.06e-05 | 3 | 157 | 2 | 32747172 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 20373053 | ||
| Pubmed | IGF-1 facilitates thrombopoiesis primarily through Akt activation. | 6.06e-05 | 3 | 157 | 2 | 29802222 | |
| Pubmed | RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. | 6.06e-05 | 3 | 157 | 2 | 20595512 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 12121420 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 10625627 | ||
| Pubmed | Dampening of death pathways by schnurri-2 is essential for T-cell development. | 6.06e-05 | 3 | 157 | 2 | 21475200 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 26179907 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 31592798 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 35879412 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 31552021 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 1321336 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 18955699 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 8261111 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24180670 | ||
| Pubmed | Cigarette smoke extract stimulates PCSK9 production in HepG2 cells via ROS/NF‑κB signaling. | 6.06e-05 | 3 | 157 | 2 | 33760160 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 8649400 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 7.01e-05 | 18 | 157 | 3 | 18834073 | |
| Pubmed | 7.01e-05 | 18 | 157 | 3 | 23534349 | ||
| Pubmed | HIVEP2 CHD8 NCKAP5 MUC12 MAP3K4 ARRB2 CDC42EP2 PLEKHA5 KDM2A GAB1 | 7.78e-05 | 486 | 157 | 10 | 20936779 | |
| Pubmed | DOCK3 KIAA0930 TBC1D30 PPFIBP1 SHROOM4 HIVEP3 KDM2A MINAR1 MAML3 UNC80 | 8.75e-05 | 493 | 157 | 10 | 15368895 | |
| Pubmed | WDR36 PPFIBP1 CHD1 HUWE1 TBL3 FAM222A STAU2 TRMT1L ZC3H7B POLQ | 9.20e-05 | 496 | 157 | 10 | 31343991 | |
| Pubmed | 1.03e-04 | 102 | 157 | 5 | 11214970 | ||
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 11802795 | ||
| Pubmed | Mucin 16 is a functional selectin ligand on pancreatic cancer cells. | 1.21e-04 | 4 | 157 | 2 | 22159147 | |
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 28358707 | ||
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 34077723 | ||
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 18500345 | ||
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 9382880 | ||
| Pubmed | 1.21e-04 | 4 | 157 | 2 | 16684770 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.51e-04 | 330 | 157 | 7 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.64e-04 | 234 | 157 | 6 | chr8p23 | |
| Cytoband | 8p23.1 | 1.97e-04 | 154 | 157 | 5 | 8p23.1 | |
| Cytoband | 22q13.31 | 5.35e-04 | 46 | 157 | 3 | 22q13.31 | |
| Cytoband | 11q13.2 | 5.70e-04 | 47 | 157 | 3 | 11q13.2 | |
| Cytoband | 8p11.2 | 1.03e-03 | 14 | 157 | 2 | 8p11.2 | |
| GeneFamily | Zinc fingers CXXC-type | 3.70e-05 | 12 | 102 | 3 | 136 | |
| GeneFamily | PHD finger proteins | 1.56e-04 | 90 | 102 | 5 | 88 | |
| GeneFamily | CD molecules|Mucins | 2.15e-04 | 21 | 102 | 3 | 648 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 3.12e-04 | 5 | 102 | 2 | 1182 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.89e-04 | 394 | 102 | 9 | 471 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 4.66e-04 | 6 | 102 | 2 | 1225 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.30e-06 | 164 | 148 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k4 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.40e-05 | 75 | 148 | 6 | gudmap_kidney_P1_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 2.14e-05 | 120 | 148 | 7 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 3.87e-05 | 291 | 148 | 10 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_200 | 5.49e-05 | 139 | 148 | 7 | gudmap_kidney_P2_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.00e-05 | 32 | 148 | 4 | gudmap_kidney_adult_RenalCapsule_k1_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_500 | 1.41e-04 | 276 | 148 | 9 | gudmap_kidney_P1_CapMes_Crym_500 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Monocytes|metastatic_Brain / Location, Cell class and cell subclass | 2.76e-08 | 195 | 154 | 9 | dfc24ee09bdc20d8a38feb8a4cc5f6b54a032981 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 C15orf39 APOBEC3A RIN1 CDC42EP2 | 3.15e-08 | 198 | 154 | 9 | 8449934e20bb2a34079fb642cae0d4647b9efe51 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-08 | 199 | 154 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB3 LILRB2 CEACAM3 LILRA6 C15orf39 APOBEC3A ARRB2 VCAN CDC42EP2 | 3.43e-08 | 200 | 154 | 9 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB3 LILRB2 LILRA6 C15orf39 APOBEC3A ARRB2 VCAN EHD1 CDC42EP2 | 3.43e-08 | 200 | 154 | 9 | d237cf947d6768b022d18211e14af4adb4990708 |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | LILRB3 LILRB2 LILRA6 CHD1 APOBEC3A ARRB2 VCAN CDC42EP2 PHACTR1 | 3.43e-08 | 200 | 154 | 9 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 LILRA6 APOBEC3A ARRB2 VCAN | 3.43e-08 | 200 | 154 | 9 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FNIP2 LILRB3 TMEM121B LILRB2 APOBEC3A CDC42EP2 PLEKHO1 UNC13A | 6.38e-08 | 153 | 154 | 8 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | FNIP2 LILRB3 TMEM121B LILRB2 APOBEC3A CDC42EP2 PLEKHO1 UNC13A | 6.38e-08 | 153 | 154 | 8 | 2c46183481e6d5a7fa190a743062509465f88e56 |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | FNIP2 LILRB3 TMEM121B LILRB2 APOBEC3A CDC42EP2 PLEKHO1 UNC13A | 6.38e-08 | 153 | 154 | 8 | decc4f3098a9374a6b65c015a9d36380986290bf |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FNIP2 LILRB3 TMEM121B LILRB2 APOBEC3A CDC42EP2 PLEKHO1 UNC13A | 6.38e-08 | 153 | 154 | 8 | 36a28805c0545c2f410c74a6ca0a70d840e75715 |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | FNIP2 LILRB3 TMEM121B LILRB2 APOBEC3A CDC42EP2 PLEKHO1 UNC13A | 9.92e-08 | 162 | 154 | 8 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.98e-07 | 187 | 154 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-07 | 189 | 154 | 8 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.10e-07 | 195 | 154 | 8 | f8908657db50f1c58904dd6fee4fc23f5ae3eed6 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 4.26e-07 | 196 | 154 | 8 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.26e-07 | 196 | 154 | 8 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 197 | 154 | 8 | 2d3547107c88c7443fc6425742694e13368a71f5 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 C15orf39 APOBEC3A RIN1 | 4.60e-07 | 198 | 154 | 8 | d7620b8d24e04ce1c563fc0ebe1625e03fe78950 |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.60e-07 | 198 | 154 | 8 | 1c170655070acca00520b7cf9c510a04c0a90a8f |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-07 | 198 | 154 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-07 | 198 | 154 | 8 | 4ba72ba1f0cebc93053aae72d763c33e155b6fa4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-07 | 198 | 154 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | 99eec995aa20ac22a8dd045382bd15a15db0b87a |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | aca9f75c690c6ed952bcbdc7e1e7eef7719f54ca |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 4.78e-07 | 199 | 154 | 8 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | 3e09b3c2e2c57e5248981293020d2434e898e3e1 |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | ae6b4b4557c6a9223acdee2a79bc780c5916d38a |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.78e-07 | 199 | 154 | 8 | 73a98d19871ffbc3c631de330998d42e9afa6da2 | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | 4eed28ef8c74d7131eeeabdd732a682d91e034dd |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | f234533254fd82b1ef2041e8405fe201d874018b |
| ToppCell | COVID-19_Convalescent-Myeloid-Non-classical_Monocyte|COVID-19_Convalescent / Disease group, lineage and cell class | KIAA0930 LILRB3 LILRB2 PECAM1 CEACAM3 APOBEC3A RIN1 CDC42EP2 | 4.78e-07 | 199 | 154 | 8 | 5253948a1d7fc3da571860e14cdde4e18222e13b |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | FNIP2 LILRB2 PECAM1 CEACAM3 C15orf39 APOBEC3A ARRB2 CDC42EP2 | 4.96e-07 | 200 | 154 | 8 | 52f2a97af2d77dd068b19531dad1b3fba2601e90 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.96e-07 | 200 | 154 | 8 | 5ea3e74687893b8ca6cb915f0f14a14d4692775c | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | LILRB3 LILRB2 CEACAM3 LILRA6 C15orf39 APOBEC3A ARRB2 CDC42EP2 | 4.96e-07 | 200 | 154 | 8 | d39bf03817b76c9dfcbcd868341b51bb8601ea9b |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.96e-07 | 200 | 154 | 8 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | fe7f8b04067b6680b69c8523f0fa514ef97207e2 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.96e-07 | 200 | 154 | 8 | 0855ebb10b925664aa5cf813d97e97683c46180d | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.28e-06 | 181 | 154 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 3.40e-06 | 182 | 154 | 7 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-06 | 183 | 154 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.52e-06 | 183 | 154 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-06 | 183 | 154 | 7 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 184 | 154 | 7 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 184 | 154 | 7 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 4.06e-06 | 187 | 154 | 7 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 154 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 154 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 154 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 4.36e-06 | 189 | 154 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 154 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.51e-06 | 190 | 154 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.51e-06 | 190 | 154 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.51e-06 | 190 | 154 | 7 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.67e-06 | 191 | 154 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-06 | 191 | 154 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.67e-06 | 191 | 154 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.83e-06 | 192 | 154 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.83e-06 | 192 | 154 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-06 | 192 | 154 | 7 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.83e-06 | 192 | 154 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.83e-06 | 192 | 154 | 7 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Monocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.00e-06 | 193 | 154 | 7 | e67e960a5312ed73c5169795cb282e431866b9c1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 193 | 154 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.00e-06 | 193 | 154 | 7 | ddbd8944661ac3b0b5fe63471bdc24ba05598017 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.00e-06 | 193 | 154 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Monocytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.17e-06 | 194 | 154 | 7 | ed14fbb3b4622798f8e02dc91bbe464a6fed8310 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.17e-06 | 194 | 154 | 7 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.17e-06 | 194 | 154 | 7 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-06 | 194 | 154 | 7 | d2f6c8900b5c448eede8047ca964e94b19bd6ca5 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.35e-06 | 195 | 154 | 7 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-06 | 195 | 154 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-06 | 195 | 154 | 7 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.35e-06 | 195 | 154 | 7 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-06 | 195 | 154 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.35e-06 | 195 | 154 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 195 | 154 | 7 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.35e-06 | 195 | 154 | 7 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.53e-06 | 196 | 154 | 7 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | distal-1-Hematologic-Interstitial_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.72e-06 | 197 | 154 | 7 | 9e5df74aeeefa4d928ec07c036aacb549c797f30 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.72e-06 | 197 | 154 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-06 | 197 | 154 | 7 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | normal_Lung-Myeloid_cells-Monocytes|normal_Lung / Location, Cell class and cell subclass | 5.72e-06 | 197 | 154 | 7 | f32f1a0455c2cfdd5f187b10f6a3fd4877874c09 | |
| ToppCell | control-Myeloid|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.91e-06 | 198 | 154 | 7 | abf08cde20c1843d54ba008c1db5a6ab376c761e | |
| ToppCell | ASK452-Immune-Macrophages|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.91e-06 | 198 | 154 | 7 | 92293d389bf7d76ba057613e573c2595676ded85 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 198 | 154 | 7 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.91e-06 | 198 | 154 | 7 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 5.91e-06 | 198 | 154 | 7 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.91e-06 | 198 | 154 | 7 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.91e-06 | 198 | 154 | 7 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 5.91e-06 | 198 | 154 | 7 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 5.91e-06 | 198 | 154 | 7 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.11e-06 | 199 | 154 | 7 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 6.11e-06 | 199 | 154 | 7 | 3e14f9a62d6414add8d5f681be184b4625001838 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.11e-06 | 199 | 154 | 7 | cedae98b71fbed55b04f1e56418eb8de4f3e77d9 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 199 | 154 | 7 | aa30a57c0907d012942e7babdbff6ea4d01d7798 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.11e-06 | 199 | 154 | 7 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 199 | 154 | 7 | 7e5a56bb2ac441a8fa4ad0b928f9c0c82d128190 | |
| Computational | Neighborhood of CARD15 | 2.65e-05 | 70 | 91 | 6 | GNF2_CARD15 | |
| Computational | Neighborhood of CASP1 | 4.10e-05 | 111 | 91 | 7 | GNF2_CASP1 | |
| Computational | Neighborhood of S100A4 | 4.51e-05 | 47 | 91 | 5 | GNF2_S100A4 | |
| Computational | Neighborhood of HCK | 1.40e-04 | 94 | 91 | 6 | GNF2_HCK | |
| Computational | Neighborhood of TNFRSF1B | 2.15e-04 | 65 | 91 | 5 | GNF2_TNFRSF1B | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.49e-06 | 188 | 150 | 9 | 5116_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 5.11e-06 | 191 | 150 | 9 | 4451_UP | |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 6.05e-06 | 195 | 150 | 9 | 429_UP | |
| Disease | white matter microstructure measurement | 2.18e-05 | 390 | 143 | 10 | EFO_0005674 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 9.20e-05 | 93 | 143 | 5 | C1535926 | |
| Disease | eosinophil percentage of granulocytes | 1.51e-04 | 234 | 143 | 7 | EFO_0007996 | |
| Disease | unipolar depression, depressive symptom measurement | 2.67e-04 | 26 | 143 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | white matter integrity, age at assessment | 2.67e-04 | 26 | 143 | 3 | EFO_0004641, EFO_0008007 | |
| Disease | age at first birth measurement | 3.04e-04 | 120 | 143 | 5 | EFO_0009101 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0801767 | |
| Disease | Intellectual Disability | HIVEP2 CHD8 UROC1 SYNGAP1 SHROOM4 PNPT1 ERLIN2 SETBP1 PHACTR1 | 3.46e-04 | 447 | 143 | 9 | C3714756 |
| Disease | myeloid leukemia (is_marker_for) | 4.82e-04 | 7 | 143 | 2 | DOID:8692 (is_marker_for) | |
| Disease | arachidonate 15-lipoxygenase B measurement | 4.82e-04 | 7 | 143 | 2 | EFO_0801391 | |
| Disease | Profound Mental Retardation | 5.95e-04 | 139 | 143 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.95e-04 | 139 | 143 | 5 | C0025363 | |
| Disease | Mental deficiency | 5.95e-04 | 139 | 143 | 5 | C0917816 | |
| Disease | melanoma (implicated_via_orthology) | 6.41e-04 | 8 | 143 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | myelofibrosis (is_implicated_in) | 6.41e-04 | 8 | 143 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | gait measurement | 8.40e-04 | 150 | 143 | 5 | EFO_0007680 | |
| Disease | intraocular pressure measurement | 8.74e-04 | 509 | 143 | 9 | EFO_0004695 | |
| Disease | basophil count, eosinophil count | 1.17e-03 | 241 | 143 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | cup-to-disc ratio measurement | 1.22e-03 | 430 | 143 | 8 | EFO_0006939 | |
| Disease | hearing impairment | 1.34e-03 | 98 | 143 | 4 | C1384666 | |
| Disease | Neurobehavioral Manifestations | 1.49e-03 | 12 | 143 | 2 | C0525041 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 1.49e-03 | 12 | 143 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.74e-03 | 49 | 143 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.76e-03 | 13 | 143 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.96e-03 | 51 | 143 | 3 | cv:CN043650 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.05e-03 | 364 | 143 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Carcinoma, Granular Cell | 2.49e-03 | 116 | 143 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.49e-03 | 116 | 143 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.49e-03 | 116 | 143 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.49e-03 | 116 | 143 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.49e-03 | 116 | 143 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.49e-03 | 116 | 143 | 4 | C0001418 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.78e-03 | 286 | 143 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.12e-03 | 60 | 143 | 3 | C4722327 | |
| Disease | serum IgG measurement | 3.39e-03 | 18 | 143 | 2 | EFO_0004565 | |
| Disease | alpha synuclein measurement | 3.39e-03 | 18 | 143 | 2 | EFO_0009323 | |
| Disease | Myeloid Leukemia | 3.39e-03 | 18 | 143 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.39e-03 | 18 | 143 | 2 | C0023466 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.78e-03 | 19 | 143 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | cortical surface area change measurement, age at assessment | 3.78e-03 | 19 | 143 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | lingual gyrus volume measurement | 3.78e-03 | 19 | 143 | 2 | EFO_0010314 | |
| Disease | Coronary Arteriosclerosis | 3.91e-03 | 65 | 143 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 3.91e-03 | 65 | 143 | 3 | C1956346 | |
| Disease | corneal hysteresis | 4.18e-03 | 20 | 143 | 2 | EFO_0010066 | |
| Disease | Thyroid preparation use measurement | 4.20e-03 | 217 | 143 | 5 | EFO_0009933 | |
| Disease | coffee consumption measurement, neuroticism measurement | 4.26e-03 | 67 | 143 | 3 | EFO_0006781, EFO_0007660 | |
| Disease | diaphragmatic hernia | 4.61e-03 | 21 | 143 | 2 | EFO_0008561 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 4.61e-03 | 21 | 143 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Prostate cancer, familial | 4.62e-03 | 69 | 143 | 3 | C2931456 | |
| Disease | Nonorganic psychosis | 4.62e-03 | 69 | 143 | 3 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPLGSRESYSDSMHS | 231 | Q9UPW8 | |
| PPSTAPMAVSASHRG | 106 | Q8NBF4 | |
| PEGSPTLHFSMGELS | 456 | Q8N1M1 | |
| GHETPMTIPEFFRES | 46 | Q5FVE4 | |
| PSMTATHFPRVYGVS | 271 | Q6ZT62 | |
| VASAMHSSRYPSPAE | 31 | Q5U5X8 | |
| SLPSTHIFGTPMGAV | 621 | P55198 | |
| GHSSATSASLPFMPF | 2461 | Q9HCK8 | |
| KLGSMHSPFRARSEP | 236 | Q9BT22 | |
| GPVMPSDYQHSSSRL | 451 | Q9BWU1 | |
| SSFSSPVGMVFHPRS | 406 | Q9H7T0 | |
| MGFHFTTGIPAPSTE | 2666 | P13611 | |
| FPSTTPGIQSLMHEF | 471 | A4D0V7 | |
| ASGPRHLMDPHIFTS | 6 | P31941 | |
| HSPSMTATHFPRVYG | 261 | Q9Y3L3 | |
| MAASTSFPPRLDSEG | 2931 | Q8WXG9 | |
| VLSDSRPAMAPGSSH | 411 | Q9BR76 | |
| HSPLTSGMRVAFPDT | 211 | Q96GS6 | |
| SSATGFSAIPHLMIP | 506 | Q9H694 | |
| MDHRASSSGPRSPLD | 1666 | O14646 | |
| FGSSAFPPHSVMLQT | 1351 | Q9BXF3 | |
| PQPSAETTRHFLMSD | 181 | P32121 | |
| FSSHTPCGDASIIPM | 136 | Q9BUB4 | |
| TFSRQPFSGDPHMVS | 876 | Q13367 | |
| GLEHSSDPSAIMAPF | 246 | P50281 | |
| SHTDMRPLSGGLIAF | 206 | O95631 | |
| GMEISFAPATSHEAP | 381 | Q9Y5P3 | |
| FLRPSSSNHSVGPMR | 136 | Q6PCD5 | |
| HSLSSRIGSPPSVVM | 1046 | Q9H0B3 | |
| PSVVMLVGSSPRTCH | 1056 | Q9H0B3 | |
| MTYLSAPNASVTGPH | 1496 | Q9H1A4 | |
| MSLTPSQGTHTFDPV | 321 | P53677 | |
| DYLRVASGPMPVHTT | 141 | A8MXZ1 | |
| ASPSMAGHEPRVPTS | 2966 | Q8WXI7 | |
| TGMASSIVPGTFHPT | 861 | Q99102 | |
| SSLSSRGTPTRMFPH | 56 | Q8WUM0 | |
| RGTPTRMFPHHSITE | 61 | Q8WUM0 | |
| VHPGAATVPTMSAAF | 51 | Q15038 | |
| SAHSTVVLLFFGPPM | 241 | O95013 | |
| FAHVSMGSPQARPSS | 366 | Q96JK9 | |
| MSDIRSGPSQHLDSP | 536 | Q02846 | |
| QSPTSPFMGSLRALH | 36 | Q86W92 | |
| DYLRVASGPMPVHTT | 141 | Q86YD7 | |
| SSRFPMSPRPDSVHS | 561 | Q13480 | |
| ADINSSLPPMSTFHR | 271 | P15884 | |
| SPASPMHERVTSFST | 276 | Q6ICG6 | |
| EMFSLSTFHSLSPPG | 6 | Q13387 | |
| EGPAFHPSTMAFSVR | 381 | Q86SJ6 | |
| PAVAMHSAGTPRAES | 41 | Q6ZUT6 | |
| DYLRVASGPMPVHTT | 141 | A8MWA6 | |
| FMLTQPHSVSESPGK | 21 | P01721 | |
| DYLRVASGPMPVHTT | 141 | P0C7W9 | |
| VHTAPPAEASMGTRV | 536 | Q8NBP7 | |
| ASELTFEGVPMTHSP | 171 | Q9H1R3 | |
| ESFSTPKFHISPTGM | 231 | P16284 | |
| DINTSLPPMSSFHRG | 286 | Q99081 | |
| GADRSSQVSSYPMHP | 241 | Q86SU0 | |
| FPMSPVTSAHAGTYR | 381 | Q8N423 | |
| FPMSPVTSAHAGTYR | 381 | Q6PI73 | |
| FPMSPVTSAHAGTYR | 381 | O75022 | |
| SDTHSRTDPIQMPYG | 96 | O15442 | |
| GDKPSATIHASRTMP | 21 | P54368 | |
| LDPFFSREPSSMHIS | 3931 | Q7Z6Z7 | |
| SFASMHRFGPIPLGS | 216 | Q16795 | |
| PFSATMSPVRLHSSN | 331 | Q9BZF3 | |
| TNHRLSLPMPASGTS | 406 | Q14451 | |
| VEAVFSMGPVTPAHA | 176 | Q9H7L2 | |
| AMHLPRSSFSKVPGT | 61 | Q8TAX0 | |
| LTSTSGPGFHLMLPF | 41 | O94905 | |
| SPFSPRHTFLPSGSM | 1121 | Q96RW7 | |
| AAMRSDSLVPGTHTP | 91 | Q9C0D0 | |
| SSTHGPAERSPLMCV | 291 | O60906 | |
| PEARSSFDEMLPGTH | 866 | Q02218 | |
| FLRASRPSAMTHEAP | 266 | Q8NC74 | |
| IHDPVSPRGMVTRSS | 726 | Q9Y2K7 | |
| SSDMISPPLGDFRHT | 26 | O14613 | |
| FGHSSEAPPRTDTMD | 1901 | Q8IZD9 | |
| PVARTMDFLSPHGSA | 471 | P15391 | |
| SPKGRFVMLLPSSTH | 406 | Q9Y3I1 | |
| SNLAHSTPVDMPSRG | 216 | Q9P278 | |
| SRTTEDVSMPPLHRG | 251 | Q8ND61 | |
| SISMRHAFVPFPGGS | 2311 | O75417 | |
| LAPGRGPSHSSAFSM | 196 | P40198 | |
| GSPRSSSESHSPLYM | 456 | P41182 | |
| MACLHETRTPSPSFG | 1 | Q12852 | |
| SPVHGSMDCSPSLRA | 391 | P16109 | |
| SAHPDASSARPTRML | 46 | Q9P2N6 | |
| STSAHLVPRAPGSLM | 106 | O15037 | |
| FPHSAEMLGSPLVSV | 61 | Q5JT82 | |
| FSPIRSEPRSPSHSM | 741 | Q03164 | |
| LTGSFPLMSHPSRRG | 326 | Q9NW75 | |
| SGSTMSLNHEAPTPR | 931 | Q9Y3R0 | |
| MGSEPLAHSSRFLPS | 386 | Q8NDH6 | |
| SGPIAFAHKRMTPSS | 241 | Q9UNI6 | |
| EPTTDSFIAVMHGPT | 91 | Q9H4M9 | |
| DYLRVASGPMPVHTT | 141 | A8MXJ8 | |
| MGTVHARSLEPLPSS | 1 | Q9Y512 | |
| MASSLFRVPEPPSSH | 766 | Q8N137 | |
| DYLRVASGPMPVHTT | 141 | P0C7X0 | |
| VTFGSVHPSDVLDMP | 176 | Q9UNL4 | |
| RPRPADSSFSLHGME | 226 | E9PI22 | |
| SEGPSDDSASPRMFH | 651 | Q9UPX6 | |
| SAHSTVVLLFFGPPM | 241 | Q6IEY1 | |
| SPIRMFASFHPSAST | 446 | O43189 | |
| TRSMPSDARSHGSPA | 1176 | Q9Y6R4 | |
| MSGHFLLAPIPESSS | 6 | Q6T310 | |
| SRTHFDPMGVRTDAP | 666 | Q7Z2T5 | |
| MRLPEASGPSFVSSH | 106 | Q13671 | |
| MRPALGHPRSVSSAS | 1 | Q9BXQ6 | |
| PAHAPSSSFTVMALG | 1021 | O14513 | |
| DYLRVASGPMPVHTS | 141 | A8MX19 | |
| DYLRVASGPMPVHTT | 141 | P0C7W8 | |
| QFSPVAGVHSPMASS | 496 | Q9Y6Q9 | |
| EEGSSLASMPHPLRS | 1041 | Q9ULL8 | |
| PMTFSEPFGPHSTLS | 206 | Q6ZUB1 | |
| HPSRPFTMASCSRDS | 661 | Q8IZU2 | |
| SREHPFPGTLMHSAA | 51 | A6NJG2 | |
| RTPDGASRSSHEPME | 141 | P0DKV0 | |
| APTPSAMHEARDFIT | 651 | Q8TCS8 | |
| PPTRGHLMAVASTST | 166 | Q53GL0 | |
| DYLRVASGPMPVHTT | 141 | P0C7V4 | |
| RSGFEMSRPIPSHLT | 471 | O94818 | |
| RPRPADSSFSLHGME | 226 | P0DMB1 | |
| SPTRSLSMDAPRGVH | 196 | Q13326 | |
| PMSEAFHPTVTGESL | 236 | Q96A09 | |
| GFSERSSTPHCTMPS | 1871 | Q8NFU7 | |
| HSPLTSGMRVAFPDT | 191 | Q5VST6 | |
| YLSFSPTTPMSSHGR | 171 | Q9UKV5 | |
| VPVTTDAMPRTNFHS | 631 | Q6ZRI6 | |
| RTPTHEMFVGFTPSP | 461 | Q13492 | |
| MSPESGHSRIFEATA | 1 | A4UGR9 | |
| SIRTEPPASHGSFHM | 171 | Q9UK80 | |
| PLVLEGTFPMSSSHD | 561 | Q6AWC2 | |
| RSFMSGRPSQTPEHD | 1001 | Q8N2C7 | |
| FRDHMKSVIPSDGPS | 41 | P02787 | |
| MSTVGLFHFPTPLTR | 1 | Q9H3J6 | |
| IGPMSCFISRHSIPS | 101 | P62487 | |
| SGPPHMKSFVTRVSV | 231 | Q9NUL3 | |
| ASIHRGSIPAMSYAP | 6 | Q96PV0 | |
| SLRDMPHPLAGSSSE | 16 | Q5VWJ9 | |
| SSLVSSRFSPHMVAP | 281 | Q9HCS4 | |
| MYSGHPLGLFPSSRS | 156 | Q96N76 | |
| LPCPRTSSRHFSEAM | 26 | Q6RVD6 | |
| TEMPFPEPSRGSSHS | 451 | Q9P2F5 | |
| AIHTAPVATMAFDPT | 106 | Q12788 | |
| PMPERSHLTEPSSSG | 1116 | Q96MS0 | |
| TYTMATAPHPEAGRL | 1661 | Q5T1R4 | |
| PDPTVASGSSMFLRF | 856 | Q9Y6L7 | |
| LPTAPFASSIGSHNM | 101 | P08922 | |
| TVHFPQMSRSFSKPG | 901 | Q9Y2I9 | |
| ACPLSSQSMPHFGTR | 76 | P40238 | |
| CRSLESSPHSLVPMG | 126 | A8MZF0 | |
| VTTGPIFSMALHPSE | 311 | Q9H967 | |
| MSEPHRVQFTSLPGS | 1 | Q9NPG3 | |
| MALRPEDPSSGFRHS | 1 | Q9BXU3 | |
| YPTRTSMDSHGNPVT | 381 | Q9ULT6 | |
| TSDYAVHPMSPVGRT | 131 | Q9HAU0 | |
| IPPSLRGSHSFDERM | 556 | P31629 | |
| SHTLGAASPFMRPTV | 1076 | Q9Y6X0 | |
| LSPYPFMRGEHNSTS | 91 | Q6ZP80 | |
| LPATYMNLGPSTSHE | 1356 | Q04912 | |
| GLARFATTPYMEPSH | 266 | A6NNM8 | |
| PITSISFRTDGHPVM | 291 | Q8NI36 | |
| SSMGAPRTHGPSTFD | 676 | Q9UGR2 | |
| GPTHTIAFPDSTTMP | 316 | Q9UKN1 | |
| RSPGSTQTMHFPESS | 506 | Q9UKN1 | |
| GPLMLSPSSLFSAFH | 761 | Q92539 | |
| IGSKRTASPPHIFAM | 396 | Q8NEV4 |